|
| Exchange Received Time 04/07/2018 13:08:50 Exchange Disseminated Time 04/07/2018 13:08:58 Time Taken 00:00:08 | Meeting of the Board of Directors of the Company is scheduled to be held on Friday 13th July 2018 inter alia, to consider and approve the following items.
to acquire a majority stake in PSL SoftTechPvt. Ltd providing IT and implementing innovative technologies which involves Data Warehousing, Analytics, Collaboration, Automation, and Artificial Intelligence in Clinical Research.
to acquire a majority stake in Global Allied Pharmaceuticals Private Limited providing Clinical Research Services. Currently Gapsos operates over 10 countries including Brazil, Maxico, Russia, France, Japan and China in partnering with Global Allied Pharmaceuticals LLC, USA.
to acquire Clinical Data Management, Monitoring and Conducting hardware's and software's for conducting and monitoring clinical trials from Hysynth Biotechnologies Private Limited.
to consider and take on record the un-audited financial results of the Company for the quarter ended 30th June 2018
|
|
|